INR 105.67
(2.25%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 127.38 Million INR | -44.69% |
2022 | 230.29 Million INR | -7.46% |
2021 | 248.84 Million INR | 13.41% |
2020 | 219.41 Million INR | -12.52% |
2019 | 250.8 Million INR | 5.45% |
2018 | 237.84 Million INR | 22.29% |
2017 | 194.49 Million INR | -4.12% |
2016 | 202.85 Million INR | 39.4% |
2015 | 145.51 Million INR | -27.33% |
2014 | 200.23 Million INR | -14.6% |
2013 | 234.45 Million INR | 34.92% |
2012 | 173.76 Million INR | 66.47% |
2011 | 104.38 Million INR | 64.45% |
2010 | 63.47 Million INR | -18.62% |
2009 | 77.99 Million INR | -0.95% |
2008 | 78.74 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 25.64 Million INR | -32.13% |
2023 Q3 | 35.68 Million INR | -50.55% |
2023 FY | 127.38 Million INR | -44.69% |
2023 Q1 | 51.18 Million INR | -23.34% |
2023 Q2 | 72.14 Million INR | 40.96% |
2023 Q4 | 37.79 Million INR | 5.92% |
2022 Q4 | 66.76 Million INR | 3.48% |
2022 Q2 | 50.83 Million INR | 6.53% |
2022 Q1 | 47.72 Million INR | -24.75% |
2022 FY | 230.29 Million INR | -7.46% |
2022 Q3 | 64.52 Million INR | 26.92% |
2021 Q4 | 63.41 Million INR | -3.27% |
2021 FY | 248.84 Million INR | 13.41% |
2021 Q1 | 64.67 Million INR | 271.56% |
2021 Q2 | 55.19 Million INR | -14.66% |
2021 Q3 | 65.55 Million INR | 18.78% |
2020 Q4 | 17.4 Million INR | -81.37% |
2020 Q2 | 57.31 Million INR | 11.78% |
2020 Q3 | 93.42 Million INR | 62.99% |
2020 Q1 | 51.27 Million INR | 0.08% |
2020 FY | 219.41 Million INR | -12.52% |
2019 Q1 | 60.84 Million INR | 15.7% |
2019 Q2 | 66.03 Million INR | 8.52% |
2019 Q3 | 72.69 Million INR | 10.09% |
2019 FY | 250.8 Million INR | 5.45% |
2019 Q4 | 51.23 Million INR | -29.53% |
2018 FY | 237.84 Million INR | 22.29% |
2018 Q4 | 52.58 Million INR | -22.38% |
2018 Q3 | 67.74 Million INR | 7.08% |
2018 Q2 | 63.26 Million INR | 33.41% |
2018 Q1 | 47.42 Million INR | 0.0% |
2017 FY | 194.49 Million INR | -4.12% |
2016 FY | 202.85 Million INR | 39.4% |
2015 Q1 | 30.1 Million INR | -24.87% |
2015 FY | 145.51 Million INR | -27.33% |
2015 Q2 | 27.88 Million INR | -7.37% |
2014 FY | 200.23 Million INR | -14.6% |
2014 Q4 | 40.07 Million INR | 39.06% |
2014 Q3 | 28.81 Million INR | -56.35% |
2014 Q2 | 66.01 Million INR | 1.08% |
2014 Q1 | 65.31 Million INR | 71.29% |
2013 Q2 | 66.34 Million INR | 10.0% |
2013 FY | 234.45 Million INR | 34.92% |
2013 Q1 | 60.31 Million INR | 41.71% |
2013 Q4 | 38.13 Million INR | -45.26% |
2013 Q3 | 69.65 Million INR | 4.98% |
2012 Q1 | 34.19 Million INR | 193.81% |
2012 Q2 | 37.85 Million INR | 10.7% |
2012 Q3 | 60.36 Million INR | 59.44% |
2012 Q4 | 42.56 Million INR | -29.49% |
2012 FY | 173.76 Million INR | 66.47% |
2011 Q3 | 31.2 Million INR | 0.0% |
2011 FY | 104.38 Million INR | 64.45% |
2011 Q4 | 11.63 Million INR | -62.69% |
2010 FY | 63.47 Million INR | -18.62% |
2009 FY | 77.99 Million INR | -0.95% |
2008 FY | 78.74 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aarti Drugs Limited | 1.16 Billion INR | 89.089% |
Albert David Limited | 1.02 Billion INR | 87.587% |
Alembic Limited | 872.45 Million INR | 85.4% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -1767.742% |
Hester Biosciences Limited | 908.84 Million INR | 85.984% |
Hikal Limited | 4.46 Billion INR | 97.146% |
Ind-Swift Limited | 946.56 Million INR | 86.543% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 69.115% |
Unichem Laboratories Limited | 6.72 Billion INR | 98.106% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 99.197% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | 72.04% |
Bajaj HealthCare Limited | 985.34 Million INR | 87.073% |
Brooks Laboratories Limited | 51.18 Million INR | -148.886% |
Eris Lifesciences Limited | 4.94 Billion INR | 97.423% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 95.013% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | 70.954% |
Wanbury Limited | 978.96 Million INR | 86.988% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 95.857% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.612% |
FDC Limited | 3.49 Billion INR | 96.36% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 98.906% |
Gufic Biosciences Limited | 1.18 Billion INR | 89.265% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 94.003% |
Innova Captab Limited | 931.03 Million INR | 86.318% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 94.213% |
Ipca Laboratories Limited | 18.98 Billion INR | 99.329% |
Jubilant Pharmova Limited | 14.45 Billion INR | 99.119% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 88.142% |
Lupin Limited | 125.09 Billion INR | 99.898% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | 21.481% |
Medico Remedies Limited | 59.67 Million INR | -113.456% |
Morepen Laboratories Limited | 1.98 Billion INR | 93.591% |
Nectar Lifesciences Limited | 932.7 Million INR | 86.343% |
Orchid Pharma Limited | 800.77 Million INR | 84.093% |
Procter & Gamble Health Limited | 2.99 Billion INR | 95.747% |
RPG Life Sciences Limited | 1.63 Billion INR | 92.212% |
Sigachi Industries Limited | 579.88 Million INR | 78.034% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.917% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 90.92% |
Themis Medicare Limited | 1.12 Billion INR | 88.685% |
Vaishali Pharma Limited | 84.02 Million INR | -51.591% |
Venus Remedies Limited | 1.91 Billion INR | 93.353% |
Windlas Biotech Limited | 1 Billion INR | 87.344% |
ZIM Laboratories Limited | 1.01 Billion INR | 87.426% |
Sakar Healthcare Limited | 204.07 Million INR | 37.583% |
Aurobindo Pharma Limited | 55.65 Billion INR | 99.771% |
Divi's Laboratories Limited | 14.17 Billion INR | 99.101% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 94.85% |
Mankind Pharma Limited | 29.27 Billion INR | 99.565% |
Sequent Scientific Limited | 2.9 Billion INR | 95.61% |
Laurus Labs Limited | 11.9 Billion INR | 98.93% |
Neuland Laboratories Limited | 2.92 Billion INR | 95.652% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 99.139% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 99.729% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.898% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 93.917% |
Wockhardt Limited | 8.48 Billion INR | 98.498% |
Bal Pharma Limited | 555.62 Million INR | 77.075% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.867% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 91.025% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -118.535% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 94.142% |
Shilpa Medicare Limited | 3.33 Billion INR | 96.18% |
Valiant Laboratories Limited | 138.02 Million INR | 7.715% |
Ajanta Pharma Limited | 30.46 Billion INR | 99.582% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -796.222% |
Granules India Limited | 10.31 Billion INR | 98.765% |
Medicamen Biotech Limited | 335.16 Million INR | 61.995% |
Syncom Formulations (India) Limited | 345.63 Million INR | 63.146% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.8% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.405% |
NATCO Pharma Limited | 10.05 Billion INR | 98.734% |
Suven Life Sciences Limited | 109.75 Million INR | -16.064% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -175.977% |
Strides Pharma Science Limited | 9.16 Billion INR | 98.61% |
Indoco Remedies Limited | 12.06 Billion INR | 98.944% |
Lasa Supergenerics Limited | 291.17 Million INR | 56.253% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 95.86% |